Diclofenamide

Diclofenamide
Clinical data
AHFS/Drugs.com	International Drug Names
MedlinePlus	a601233
ATC code	S01EC02 (WHO) ;
Pharmacokinetic data
Protein binding	55%
Identifiers
	IUPAC name 4,5-Dichlorobenzene-1,3-disulfonamide;
CAS Number	120-97-8 ;
PubChem CID	3038;
IUPHAR/BPS	6807;
DrugBank	DB01144 ;
ChemSpider	2930 ;
UNII	VVJ6673MHY;
KEGG	D00518 ;
ChEBI	CHEBI:101085 ;
ChEMBL	ChEMBL17 ;
CompTox Dashboard (EPA)	DTXSID1022922 ;
ECHA InfoCard	100.004.037
Chemical and physical data
Formula	C6H6Cl2N2O4S2
Molar mass	305.14 g·mol−1
3D model (JSmol)	Interactive image;
Melting point	228.5 °C (443.3 °F)
	SMILES Clc1c(cc(cc1Cl)S(=O)(=O)N)S(=O)(=O)N;
	InChI InChI=1S/C6H6Cl2N2O4S2/c7-4-1-3(15(9,11)12)2-5(6(4)8)16(10,13)14/h1-2H,(H2,9,11,12)(H2,10,13,14) ; Key:GJQPMPFPNINLKP-UHFFFAOYSA-N ;
	(what is this?) (verify)

Diclofenamide (or dichlorphenamide) is a sulfonamide and a carbonic anhydrase inhibitor of the meta-disulfamoylbenzene class. Dichlorphenamide as a carbonic anhydrase inhibitor is used for the treatment of acute angle closure glaucoma. While Dichlorphenamide does contain two sulfate groups within the structure, it falls under the class of a first generation carbonic anhydrase Inhibitor.